Autologous Humanized Mouse Model of Non-Small Cell Lung Cancer (NSCLC) to Investigate the Tumor-Immune Landscape and Its Response to Treatment
非小细胞肺癌 (NSCLC) 自体人源化小鼠模型,用于研究肿瘤免疫景观及其对治疗的反应
基本信息
- 批准号:10683397
- 负责人:
- 金额:$ 14.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-17 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Active ImmunotherapyAddressAllogenicAnimal ModelAntibody TherapyAutologousB-LymphocytesBiological ProductsBiopsyBloodBone Marrow AspirationCancer EtiologyCancer PatientCellsClinical TrialsComplexDataDevelopmentDoctor of PhilosophyDrug usageEngraftmentExhibitsFailureFlow CytometryFunctional disorderGene Expression ProfileGeneticGenetic TranscriptionGenomic approachGenomicsGoalsGrowthGrowth FactorHarvestHematopoieticHematopoietic NeoplasmsHematopoietic SystemHematopoietic stem cellsHumanImmuneImmune System DiseasesImmune systemImmunofluorescence ImmunologicImmunooncologyImmunosuppressionImmunotherapeutic agentImmunotherapyIndividualInnate Immune SystemInstitutional Review BoardsInterventionKnowledgeLocationMacrophageManuscriptsMedical OncologyMentorshipMethodsMinorityModelingMusMyelogenousMyeloid CellsNatural Killer CellsNon-Small-Cell Lung CarcinomaOperative Surgical ProceduresPathway interactionsPatientsPharmaceutical PreparationsPhenotypePhysiciansPhysiologicalPopulationPostdoctoral FellowPre-Clinical ModelPreparationPrincipal InvestigatorProteomicsProtocols documentationResearchResearch PersonnelRoleSamplingScientistSystemT-LymphocyteTimeTissuesTrainingTreatment FailureTumor PromotionTumor-associated macrophagesTumor-infiltrating immune cellsVascular Endothelial Growth Factorsanti-PD-L1bevacizumabcareerclinical trainingdrug actiondrug efficacyexhaustexhaustiongenomic datahematopoietic engraftmenthumanized mouseimmune cell infiltrateimprovedimproved outcomeindividual patientmelanomamortalitymouse developmentmouse modelneoplastic cellpatient derived xenograft modelpatient responsepembrolizumabperipheral bloodreceptorresponsetreatment responsetumortumor growthtumor microenvironmenttumor-immune system interactions
项目摘要
PROJECT SUMMARY
Non-small cell lung cancer (NSCLC) remains the major cause of cancer mortality across the globe, despite
exciting advances in immune-based therapies. These therapies, while dramatically effective in some patients,
are ineffective in the majority of NSCLC patients. The causes of treatment failure remain incompletely understood,
as is the role of the local tumor microenvironment (TME) in influencing tumor growth, both in the presence and
absence of these therapies.
To better study human tumor-immune interactions and immunotherapeutics, we have developed a humanized
mouse model that supports the engraftment of mice bearing a matched human hematopoietic system and tumor
from an individual NSCLC patient. In addition, this model is unique in its support of functional myeloid cells as
part of the innate immune system. We propose to use these autologously-engrafted humanized NSCLC PDX
models to study the TME in detail, employing flow cytometric, immunostaining and single cell genomic analyses
to characterize the transcriptional and proteomic states of the cells present. We will correlate tumor growth to
specific cell populations identified with these methods, enhancing our understanding of the pathways active in
tumor- vs blood-resident immune cells, and identifying established and possibly new networks of immune
dysfunction in the TME. Armed with this knowledge, we will probe the pathways active in these patient models
using drugs specific to the immune exhaustion and tumor promoting mechanisms we identify. Our goal is to gain
a deeper understanding of how the TME and immunotherapeutics interact, and to develop these immune avatar
mice as models that may predict a patient’s response to a particular immunotherapy.
The principal investigator is a physician-scientist, with a PhD in genetics and post-doctoral and clinical training
in Medical Oncology. His career goal is to become an independent investigator studying tumor-immune
interactions. The proposed K08 training plan will provide the candidate with mentorship and coursework to build
the expertise necessary to execute the proposed project and become independent in the field of translational
immuno-oncology.
项目总结
非小细胞肺癌(NSCLC)仍然是全球癌症死亡的主要原因,尽管
以免疫为基础的疗法取得了令人兴奋的进展。这些疗法虽然对一些患者非常有效,
对大多数非小细胞肺癌患者无效。治疗失败的原因仍然不完全清楚,
正如局部肿瘤微环境(TME)在影响肿瘤生长中的作用一样,在存在和
缺乏这些治疗方法。
为了更好地研究人类肿瘤免疫相互作用和免疫疗法,我们开发了一种人源化的
支持携带匹配的人类造血系统和肿瘤的小鼠植入的小鼠模型
来自一名非小细胞肺癌患者。此外,该模型在支持功能性髓系细胞方面是独一无二的。
先天免疫系统的一部分。我们建议使用这些自体植入的人源化非小细胞肺癌PDX
应用流式细胞术、免疫染色和单细胞基因组分析详细研究TME的模型
以确定存在的细胞的转录和蛋白质组状态。我们将把肿瘤的生长与
用这些方法鉴定了特定的细胞群体,增强了我们对活跃在
肿瘤对血液驻留的免疫细胞,识别已建立的和可能的新的免疫网络
TME的功能障碍。有了这些知识,我们将探索这些患者模型中活跃的通路
使用我们确定的针对免疫衰竭和肿瘤促进机制的特定药物。我们的目标是获得
更深入地了解TME和免疫疗法是如何相互作用的,并开发这些免疫替身
小鼠作为模型,可以预测患者对特定免疫疗法的反应。
首席研究员是一名内科科学家,拥有遗传学博士学位,博士后和临床培训。
医学肿瘤学。他的职业目标是成为一名研究肿瘤免疫的独立研究员
互动。拟议的K08培训计划将为应聘者提供指导和课程建设
执行拟议项目并在翻译领域取得独立所需的专业知识
免疫肿瘤学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Chiorazzi其他文献
Michael Chiorazzi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Chiorazzi', 18)}}的其他基金
Autologous Humanized Mouse Model of Non-Small Cell Lung Cancer (NSCLC) to Investigate the Tumor-Immune Landscape and Its Response to Treatment
非小细胞肺癌 (NSCLC) 自体人源化小鼠模型,用于研究肿瘤免疫景观及其对治疗的反应
- 批准号:
10019482 - 财政年份:2019
- 资助金额:
$ 14.82万 - 项目类别:
Autologous Humanized Mouse Model of Non-Small Cell Lung Cancer (NSCLC) to Investigate the Tumor-Immune Landscape and Its Response to Treatment
非小细胞肺癌 (NSCLC) 自体人源化小鼠模型,用于研究肿瘤免疫景观及其对治疗的反应
- 批准号:
10472627 - 财政年份:2019
- 资助金额:
$ 14.82万 - 项目类别:
Autologous Humanized Mouse Model of Non-Small Cell Lung Cancer (NSCLC) to Investigate the Tumor-Immune Landscape and Its Response to Treatment
非小细胞肺癌 (NSCLC) 自体人源化小鼠模型,用于研究肿瘤免疫景观及其对治疗的反应
- 批准号:
10248454 - 财政年份:2019
- 资助金额:
$ 14.82万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 14.82万 - 项目类别:
Research Grant